VERA: Vera Therapeutics, Inc.
Performance
VERA +26.54%
Watchlist
Select an item
Summary
VERA at a glance
VERA returned +26.54% over the past year and +9.13% a year over five years. Its worst drop in that year was -51.97%, smaller than 20% of stocks on Redstone, and its Sharpe ratio of 0.63 beats 57% of stocks on Redstone. It pays no dividends.
Current Drawdown
-45.02%
Rolling Volatility
63.63%
Actions
Metrics
Risk Indicators
Alpha24.77%
Beta1.36x
Sharpe0.63
Sortino1.03
Omega1.11
Calmar0.51
Martin1.20
Profile
About VERA
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $2.2B
- Listed
- May 2021
- Employees
- 361
- Headquarters
- Brisbane, CA
- Website
- veratx.com
Comparisons